Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Indian Heart Journal|December 3, 1998
Outcomes of primary stenting for acute myocardial infarctionU Kaul, B Singh, D Sudan, et al.
Cell Biology International|May 22, 2024
7-amino carboxycoumarin 2 inhibits lactate induced epithelial-to-mesenchymal transition via MPC1 in oral and breast cancer cellsSheikh Mohammad Umar, Arundhathi J R Dev, Akanksha Kashyap, et al.
The American Journal of Pathology|October 1, 1994
Angiogenesis in human coronary atherosclerotic plaquesE R O'Brien, M R Garvin, R Dev, et al.
Discover Oncology|May 11, 2026
Exploring the efficacy of XAV939 and LF3 in targeting β-catenin signalling in gallbladder cancer cell linesAkanksha Kashyap, Sheikh Mohammad Umar, Arundhathi J R Dev, et al.
Viruses|December 31, 2025
Repurposing FDA-Approved Drugs as Hendra Virus RNA-Dependent RNA Polymerase Inhibitors: A Comprehensive Computational Drug Discovery ApproachAnjana C Lalu, Varun Thachan Kundil, Bristow Ben Joseph, et al.
ACS Omega|March 30, 2026
Structure-Based and AI-Assisted Identification of AGPS Inhibitors for Glioma via Integrated Docking, Molecular Dynamics, and Binding Affinity ScreeningAmritha Thaikkad, Sonet Daniel Thomas, Leona Dcunha, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 9, 2013
Testosterone replacement for fatigue in hypogonadal ambulatory males with advanced cancer: a preliminary double-blind placebo-controlled trialE Del Fabbro, J M Garcia, R Dev, et al.
Molecular Biology Reports|July 6, 2024
Canonical WNT/β-catenin signaling upregulates aerobic glycolysis in diverse cancer typesMeetu Rathee, Sheikh Mohammad Umar, Arundhathi J R Dev, et al.
International Journal of Biological Macromolecules|July 10, 2025
Biophysical and molecular characterization of HuR inhibitors, CMLD-2 and Dihydrotanshinone I (DHTS), in Triple Negative Breast Cancer (TNBC)Arundhathi J R Dev, Lakshay Malhotra, Akanksha Kashyap, et al.
Molecular Diversity|July 2, 2024
Targeting AFP-RARβ complex formation: a potential strategy for treating AFP-positive hepatocellular carcinomaBhavya Banjan, Riya Vishwakarma, Krishnapriya Ramakrishnan, et al.
Pageof 5